Laboratorios Farmaceuticos Rovi Stock Key Fundamental Indicators
| LABFF Stock | USD 90.61 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Laboratorios Farmaceuticos, as well as the relationship between them.
Laboratorios Farmaceuticos' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Laboratorios Farmaceuticos' valuation are provided below:Laboratorios Farmaceuticos Rovi does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Laboratorios |
Laboratorios Farmaceuticos 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Laboratorios Farmaceuticos' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Laboratorios Farmaceuticos.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Laboratorios Farmaceuticos on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Laboratorios Farmaceuticos Rovi or generate 0.0% return on investment in Laboratorios Farmaceuticos over 90 days. Laboratorios Farmaceuticos is related to or competes with ALK-Abelló A/S, Genscript Biotech, Shanghai Junshi, Camurus AB, InnoCare Pharma, Siegfried Holding, and Zealand Pharma. Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical produ... More
Laboratorios Farmaceuticos Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Laboratorios Farmaceuticos' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Laboratorios Farmaceuticos Rovi upside and downside potential and time the market with a certain degree of confidence.
Laboratorios Farmaceuticos Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratorios Farmaceuticos' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Laboratorios Farmaceuticos' standard deviation. In reality, there are many statistical measures that can use Laboratorios Farmaceuticos historical prices to predict the future Laboratorios Farmaceuticos' volatility.Laboratorios Farmaceuticos Backtested Returns
We have found three technical indicators for Laboratorios Farmaceuticos, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Laboratorios Farmaceuticos are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Laboratorios Farmaceuticos Rovi has no correlation between past and present. Overlapping area represents the amount of predictability between Laboratorios Farmaceuticos time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Laboratorios Farmaceuticos price movement. The serial correlation of 0.0 indicates that just 0.0% of current Laboratorios Farmaceuticos price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Laboratorios Farmaceuticos Rovi has a Return On Asset of 0.1844. This is 102.11% lower than that of the Healthcare sector and 100.78% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably lower than that of the firm.
Laboratorios Farmaceuticos Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Laboratorios Farmaceuticos's current stock value. Our valuation model uses many indicators to compare Laboratorios Farmaceuticos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratorios Farmaceuticos competition to find correlations between indicators driving Laboratorios Farmaceuticos's intrinsic value. More Info.Laboratorios Farmaceuticos Rovi is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Laboratorios Farmaceuticos Rovi is roughly 2.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Laboratorios Farmaceuticos' earnings, one of the primary drivers of an investment's value.Laboratorios Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratorios Farmaceuticos' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Laboratorios Farmaceuticos could also be used in its relative valuation, which is a method of valuing Laboratorios Farmaceuticos by comparing valuation metrics of similar companies.Laboratorios Farmaceuticos is currently under evaluation in return on asset category among its peers.
Laboratorios Fundamentals
| Return On Equity | 0.39 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.93 B | |||
| Shares Outstanding | 51.32 M | |||
| Shares Owned By Insiders | 60.25 % | |||
| Shares Owned By Institutions | 17.46 % | |||
| Price To Earning | 15.16 X | |||
| Price To Book | 6.51 X | |||
| Price To Sales | 3.45 X | |||
| Revenue | 648.68 M | |||
| Gross Profit | 379.83 M | |||
| EBITDA | 204.66 M | |||
| Net Income | 153.08 M | |||
| Cash And Equivalents | 158.94 M | |||
| Cash Per Share | 2.98 X | |||
| Total Debt | 52.52 M | |||
| Debt To Equity | 0.18 % | |||
| Current Ratio | 1.77 X | |||
| Book Value Per Share | 8.28 X | |||
| Cash Flow From Operations | 149.44 M | |||
| Earnings Per Share | 3.37 X | |||
| Number Of Employees | 1.75 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 2.62 B | |||
| Total Asset | 732.68 M | |||
| Z Score | 29.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 732.68 M |
About Laboratorios Farmaceuticos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Laboratorios Farmaceuticos Rovi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratorios Farmaceuticos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratorios Farmaceuticos Rovi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. Laboratorios Farmaceticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L. Laboratorios Farmaceuticos operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1852 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Laboratorios Pink Sheet
Laboratorios Farmaceuticos financial ratios help investors to determine whether Laboratorios Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Laboratorios with respect to the benefits of owning Laboratorios Farmaceuticos security.